» Articles » PMID: 39235599

Hereditary Renal Mass Syndromes: a Pictorial Review

Overview
Publisher Springer
Date 2024 Sep 5
PMID 39235599
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary renal mass syndromes, although rare, account for at least 3-5% of kidney cancers and significantly impact affected families. Accurate diagnosis and management by radiologists are crucial as these syndromes often present at imaging with both renal and extra-renal manifestations. The radiologist may be the first to recognize these stigmata at imaging, some of which satisfy major features for diagnosis and obviate the need for genetic testing. Furthermore, radiologists contribute to lifelong imaging surveillance and locoregional treatment. This pictorial review discusses the following major hereditary renal mass syndromes with their typical renal mass appearance, extrarenal manifestations, inheritance pattern, diagnosis, and management strategies based on the most recent National Comprehensive Cancer Network guidelines: Von Hippel-Lindau syndrome, tuberous sclerosis complex, Birt-Hogg-Dube syndrome, hereditary paraganglioma/pheochromocytoma (PGL/PCC) syndrome/succinate dehydrogenase deficiency, hereditary leiomyomatosis and renal cell cancer (HLRCC)/fumarate hydratase deficiency, PTEN hamartoma syndrome, BRCA1-associated protein 1 (BAP1) tumor disposition syndrome, hereditary papillary renal cell carcinoma, and familial clear cell renal cell cancer with chromosome 3 translocation.

References
1.
Haas N, Nathanson K . Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis. 2013; 21(1):81-90. PMC: 3872053. DOI: 10.1053/j.ackd.2013.10.001. View

2.
Campbell S, Uzzo R, Karam J, Chang S, Clark P, Souter L . Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. J Urol. 2021; 206(2):209-218. DOI: 10.1097/JU.0000000000001912. View

3.
Moch H, Amin M, Berney D, Comperat E, Gill A, Hartmann A . The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022; 82(5):458-468. DOI: 10.1016/j.eururo.2022.06.016. View

4.
Chahoud J, McGettigan M, Parikh N, Boris R, Iliopoulos O, Rathmell W . Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol. 2020; 39(7):2409-2415. PMC: 8101019. DOI: 10.1007/s00345-020-03441-3. View

5.
Shetty A, Fraum T, Ballard D, Hoegger M, Itani M, Rajput M . Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's Guide. Radiographics. 2023; 43(7):e220209. DOI: 10.1148/rg.220209. View